Donepezil in the treatment of Alzheimer's disease: Long-term efficacy and safety

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 2, 2002, Pages 369-373

  Rocca, Paola ^a   Cocuzza, Elena ^a   Marchiaro, Livio ^a   Bogetto, Filippo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Alzheimer's disease; Cognitive deficit; Donepezil; Efficacy; Safety

Indexed keywords

DONEPEZIL;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVALUATION; FEMALE; HUMAN; INSOMNIA; LONG TERM CARE; MALE; NAUSEA; RATING SCALE; TREATMENT OUTCOME; VOMITING;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INDANS; MALE; NEUROPSYCHOLOGICAL TESTS; PIPERIDINES; TREATMENT OUTCOME;

EID: 0036137996     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00283-4     Document Type: Article

References (23)

1. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor
2. Cholinesterase inhibitors: A new class of psychotropic compounds
3. The relationship between donopezil and behavioral disturbances in patients with Alzheimer's disease
4. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer's disease
5. Mini mental state: A practical method for grading the cognitive state of patients for the clinician
6. The cholinergic hypothesis of Alzheimer's disease: A review of progress
7. Donepezil therapy in clinical practice
8. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease
9. Management of cognition and function: New results from the clinical trials programme of Aricept (Donepezil HCl)
10. Cholinesterase inhibitors: A therapeutic strategy for Alzheimer disease
11. Assessment of older people: Self maintaining and instrumental activities of daily living
12. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease
13. Release of Alzheimer amyloid precursor derivates stimulated by activation of muscarinic acetylcholine receptors
14. Donepezil nella Demenza di Alzheimer: Valutazione dell'efficacia a lungo termine
15. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multicentre open label extension study
16. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a multicenter, randomized, double-blind, placebo-controlled trial
17. A 24 week double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
18. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: Final analysis of a US multicentre open label study
19. A new rating scale for Alzheimer's disease
20. New therapeutic approaches to cognitive impairment
21. Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease
22. The cholinergic deficit in Alzheimer's disease